Clinical Trials Browser

Phase 2 × Vinorelbine × Sarcoma × Clear all

NCT06023641 2025-08-19

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Phase 2 Recruiting

Rhabdomyosarcoma

NCT01222715 2017-05-05

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Phase 2 Completed

87 enrolled 11 charts

Rhabdomyosarcoma, Sarcoma

NCT00003234 2014-07-28

Vinorelbine in Treating Children With Recurrent or Refractory Cancers

Phase 2 Completed

Familial ependymoma, Astrocytoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT00134641 2007-12-21

Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas

Phase 2 Completed

Sarcoma

NCT00180947 2006-09-08

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Phase 2 Unknown

Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Neoplasms, Connective and Soft Tissue